|
BR6915369D0
(pt)
|
1969-02-27 |
1973-03-13 |
Bayer Ag |
Emprego de inibidores biologicos de proteases para conservacao de orgaos tecidos e alimentos
|
|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
DE2619246A1
(de)
|
1976-04-30 |
1977-11-10 |
Bayer Ag |
Desamino-derivate des kallikrein- trypsin-inhibitors, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
|
DE2654124A1
(de)
|
1976-11-29 |
1978-06-01 |
Bayer Ag |
Derivate des trypsin-kallikrein-inhibitors aus rinderorganen (bpti) mit proteasenhemmwirkung und antiphlogistischer wirkung, ihre herstellung und ihre verwendung als arzneimittel
|
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
|
CA1093991A
(en)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
|
AT359653B
(de)
|
1979-02-15 |
1980-11-25 |
Immuno Ag |
Verfahren zur herstellung eines gewebekleb- stoffes
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
AU560584B2
(en)
|
1983-07-28 |
1987-04-09 |
Bayer Aktiengesellschaft |
Homologues of aprotinin
|
|
US4657893A
(en)
|
1984-05-09 |
1987-04-14 |
Syntex (U.S.A.) Inc. |
4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors
|
|
US4845242A
(en)
|
1987-04-28 |
1989-07-04 |
Georgia Tech Research Corporation |
Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents
|
|
US4609725A
(en)
|
1984-10-09 |
1986-09-02 |
Merck & Co., Inc. |
Cardiac atrial peptides
|
|
US5374548A
(en)
|
1986-05-02 |
1994-12-20 |
Genentech, Inc. |
Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
|
|
MX9203291A
(es)
|
1985-06-26 |
1992-08-01 |
Liposome Co Inc |
Metodo para acoplamiento de liposomas.
|
|
US5444156A
(en)
|
1985-07-12 |
1995-08-22 |
Temple University-Of The Commonwealth System Of Higher Education |
Monoclonal antibodies to human plasma prekallikrein
|
|
CA1312564C
(en)
|
1985-07-12 |
1993-01-12 |
Robert W. Colman |
Monoclonal antibodies to human plasma prekallikrein and methods of preparing and using same
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
JPH0623113B2
(ja)
|
1986-01-31 |
1994-03-30 |
浩 前田 |
癌性胸・腹水貯留抑制剤
|
|
EP0296171A4
(en)
|
1986-03-03 |
1989-11-07 |
Brigham & Womens Hospital |
ASSESSMENT PROCEDURE FOR NEPHROTOXICITY.
|
|
EP0255011A3
(en)
|
1986-07-29 |
1988-11-23 |
Miles Inc. |
Human inter-alpha-trypsin inhibitor gene
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4704692A
(en)
|
1986-09-02 |
1987-11-03 |
Ladner Robert C |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
|
US4881175A
(en)
|
1986-09-02 |
1989-11-14 |
Genex Corporation |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
|
WO1988003951A1
(en)
|
1986-11-17 |
1988-06-02 |
California Biotechnology, Inc. |
Recombinant alzheimer's amyloid protein
|
|
EP0285123A3
(en)
|
1987-04-03 |
1989-02-01 |
Stabra AG |
A method for complete mutagenesis of nucleic acids
|
|
US4966852A
(en)
|
1987-07-23 |
1990-10-30 |
Monsanto Company |
DNA clone of human tissue factor inhibitor
|
|
IL87172A
(en)
|
1987-07-23 |
1994-12-29 |
Univ Washington |
Method of isolating highly purified tissue factor inhibitor
|
|
US5106833A
(en)
|
1987-07-23 |
1992-04-21 |
Washington University |
Coagulation inhibitors
|
|
GB2208511A
(en)
|
1987-08-07 |
1989-04-05 |
Bayer Ag |
Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
|
|
DK225488D0
(da)
|
1988-04-26 |
1988-04-26 |
Novo Industri As |
Polypeptid
|
|
IL87171A
(en)
|
1987-11-23 |
1995-08-31 |
Monsanto Co |
cDNA of human tissue factor inhibitor
|
|
US5663143A
(en)
|
1988-09-02 |
1997-09-02 |
Dyax Corp. |
Engineered human-derived kunitz domains that inhibit human neutrophil elastase
|
|
US7078383B2
(en)
|
1988-09-02 |
2006-07-18 |
Dyax Corp. |
ITI-D1 Kunitz domain mutants as HNE inhibitors
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5045452A
(en)
|
1988-09-02 |
1991-09-03 |
Brigham And Women's Hospital |
Method for evaluating nephrotoxicity
|
|
EP0436597B1
(en)
|
1988-09-02 |
1997-04-02 |
Protein Engineering Corporation |
Generation and selection of recombinant varied binding proteins
|
|
US5372933A
(en)
|
1988-10-03 |
1994-12-13 |
The Scripps Research Institute |
Polypeptides that mimic receptor-induced binding sites, and methods of using same
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
ATE114332T1
(de)
|
1989-05-13 |
1994-12-15 |
Bayer Ag |
Proteinaseninhibitoren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel.
|
|
US5378614A
(en)
|
1989-08-18 |
1995-01-03 |
Novo Nordisk A/S |
Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
|
|
DK408089D0
(da)
|
1989-08-18 |
1989-08-18 |
Novo Nordisk As |
Proteiner
|
|
US5278285A
(en)
|
1990-02-01 |
1994-01-11 |
Bayer Aktiengesellschaft |
Variant of Kunitz-type inhibitor derived from the α3-chain of human type VI collagen produced by recombinant DNA technology
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
US5278144A
(en)
|
1990-09-04 |
1994-01-11 |
Cor Therapeutics, Inc. |
Antithrombosis agents
|
|
US5583107A
(en)
|
1990-09-04 |
1996-12-10 |
Cor Therapeutics, Inc. |
Agents affecting thrombosis and hemostasis
|
|
IL99585A0
(en)
|
1990-10-01 |
1992-08-18 |
Novo Nordisk As |
Aprotinin analogues,their production and pharmaceutical compositions containing them
|
|
AU641568B2
(en)
|
1990-11-13 |
1993-09-23 |
Mochida Pharmaceutical Co., Ltd. |
Polypeptide,DNA fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
|
|
US20030223977A1
(en)
|
1991-03-01 |
2003-12-04 |
Ley Arthur Charles |
Kunitz domain mutants as cathepsin G inhibitors
|
|
US5166133A
(en)
|
1991-04-17 |
1992-11-24 |
Cetus Corporation |
Method for inhibing adhesion of white blood cells to endothelial cells
|
|
CA2103059C
(en)
|
1991-06-14 |
2005-03-22 |
Paul J. Carter |
Method for making humanized antibodies
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
AU3061092A
(en)
|
1991-10-31 |
1993-06-07 |
Salk Institute Biotechnology/Industrial Associates, Inc., The |
Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states
|
|
IL104314A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them
|
|
IL104327A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Variant of human kunitz-type protease inhibitor
|
|
IL104326A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Variant of human kunitz-type protease inhibitor
|
|
IL104325A
(en)
|
1992-01-07 |
2000-10-31 |
Novo Nordisk As |
Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
|
|
IL104324A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Variant of human kunitz-type protease inhibitor
|
|
US5212091A
(en)
|
1992-03-02 |
1993-05-18 |
Monsanto Company |
Method of producing tissue factor pathway inhibitor
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
US6063764A
(en)
|
1992-06-01 |
2000-05-16 |
Washington University & Chiron Corp. |
Method for using lipoprotein associated coagulation inhibitor to treat sepsis
|
|
JPH07509229A
(ja)
|
1992-07-13 |
1995-10-12 |
コルバス・インターナショナル、インコーポレイテッド |
ウシ膵トリプシン阻害因子から誘導される因子Ｘａの阻害因子
|
|
IL107831A0
(en)
|
1992-12-02 |
1994-05-30 |
Zymogenetics Inc |
Novel human amyloid protein precursor homolog and kunitz-type inhibitor
|
|
US5436153A
(en)
|
1992-12-02 |
1995-07-25 |
Sprecher; Cindy A. |
Human amyloid protein precursor homolog and Kunitz-type inhibitor
|
|
US5426224A
(en)
|
1993-03-18 |
1995-06-20 |
The University Of North Carolina At Chapel Hill |
Mammalian DNA topoisomerase II inhibitor and method
|
|
WO1995007986A1
(en)
|
1993-09-14 |
1995-03-23 |
Genentech, Inc. |
Pharmaceutical compositions containing ecotin and homologs thereof
|
|
US5455338A
(en)
|
1993-11-05 |
1995-10-03 |
Zymogenetics, Inc. |
DNA encoding novel human kunitz-type inhibitors and methods relating thereto
|
|
US5951974A
(en)
|
1993-11-10 |
1999-09-14 |
Enzon, Inc. |
Interferon polymer conjugates
|
|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
US5759548A
(en)
|
1993-11-30 |
1998-06-02 |
Lxr Biotechnology Inc. |
Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
ES2375561T3
(es)
|
1994-01-11 |
2012-03-02 |
Dyax Corporation |
Inhibidores de la plasmina humana derivados de dominios kunitz y �?cidos nucleicos que codifican los mismos.
|
|
PT739355E
(pt)
|
1994-01-11 |
2005-01-31 |
Dyax Corp |
Proteinas de 'dominio de kunitz' inibidoras de calicreina e seus analogos
|
|
US6057287A
(en)
|
1994-01-11 |
2000-05-02 |
Dyax Corp. |
Kallikrein-binding "Kunitz domain" proteins and analogues thereof
|
|
US5795954A
(en)
|
1994-03-04 |
1998-08-18 |
Genentech, Inc. |
Factor VIIa inhibitors from Kunitz domain proteins
|
|
JP3721538B2
(ja)
|
1994-06-02 |
2005-11-30 |
メレル ファーマスーティカルズ インコーポレイテッド |
エラスターゼのパーフルオロアルキルケトン阻害剤およびそれらを製造する方法
|
|
CA2196296C
(en)
|
1994-08-05 |
2004-04-06 |
Michael A. Innis |
Production of tissue factor pathway inhibitor
|
|
US5589359A
(en)
|
1994-08-05 |
1996-12-31 |
Chiron Corporation |
Chimeric proteins
|
|
US5648331A
(en)
|
1994-08-26 |
1997-07-15 |
G.D. Searle & Co. |
Method of inhibiting tissue ischemia and reperfusion injury
|
|
EP0788546B9
(en)
|
1994-10-18 |
2007-06-13 |
Dendreon Corporation |
Nematode-extracted serine protease inhibitors and anticoagulant proteins
|
|
US6159938A
(en)
|
1994-11-21 |
2000-12-12 |
Cortech, Inc. |
Serine protease inhibitors comprising α-keto heterocycles
|
|
ES2377126T3
(es)
|
1994-12-12 |
2012-03-22 |
Omeros Corporation |
Solución de irrigación y utilización de la misma para la inhibición perioperatoria del dolor, la inflamación y/o los espasmos en una estructura vascular
|
|
JPH10510540A
(ja)
|
1994-12-12 |
1998-10-13 |
オメロス メディカル システムズ，インコーポレーテッド |
灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
|
|
US5914316A
(en)
|
1994-12-16 |
1999-06-22 |
Washington University |
Method of inhibiting intimal hyperplasia
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
ES2208737T3
(es)
|
1995-03-10 |
2004-06-16 |
Berlex Laboratories, Inc. |
Derivados de benzamidina, su preparacion y su utilizacion como anticoagulantes.
|
|
US5695760A
(en)
|
1995-04-24 |
1997-12-09 |
Boehringer Inglehiem Pharmaceuticals, Inc. |
Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
|
|
US5804376A
(en)
|
1995-05-02 |
1998-09-08 |
Incyte Pharmaceuticals, Inc. |
Pancreas-derived serpin
|
|
ZA963619B
(en)
|
1995-05-08 |
1996-11-22 |
Scios Inc |
Protease inhibitor peptides
|
|
EP0827539A2
(en)
|
1995-05-08 |
1998-03-11 |
Scios Inc. |
Kunitz type protease inhibitors
|
|
US5786328A
(en)
|
1995-06-05 |
1998-07-28 |
Genentech, Inc. |
Use of kunitz type plasma kallikrein inhibitors
|
|
US5780265A
(en)
|
1995-06-05 |
1998-07-14 |
Genentech, Inc. |
Kunitz type plasma kallikrein inhibitors
|
|
US6265150B1
(en)
|
1995-06-07 |
2001-07-24 |
Becton Dickinson & Company |
Phage antibodies
|
|
US6242414B1
(en)
|
1995-06-07 |
2001-06-05 |
Chiron Corporation |
Regulation of cytokine synthesis and release
|
|
US6126933A
(en)
|
1995-06-27 |
2000-10-03 |
Genetics Institute |
Methods of treating inflammatory bowel diseases by administering IL-11
|
|
US5672662A
(en)
|
1995-07-07 |
1997-09-30 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
|
|
JPH11512439A
(ja)
|
1995-09-14 |
1999-10-26 |
エルエックスアール バイオテクノロジー インコーポレイテッド |
リン脂質の混合物を含む抗アポトーシス活性を有する組成物
|
|
KR19990063648A
(ko)
|
1995-09-21 |
1999-07-26 |
프레드한 아룬디프 에스 |
글루타민산 데카복실라제에 대한 항체와 폴리(에틸렌 글리콜)공액물을 섬세포에 제공하는 방법
|
|
US5736364A
(en)
|
1995-12-04 |
1998-04-07 |
Genentech, Inc. |
Factor viia inhibitors
|
|
AU716923B2
(en)
|
1996-03-11 |
2000-03-09 |
Aerovance, Inc. |
Human bikunin
|
|
US6013763A
(en)
|
1996-06-04 |
2000-01-11 |
Genentech, Inc. |
Peptide variants of protein A
|
|
US5869637A
(en)
|
1996-07-22 |
1999-02-09 |
Incyte Pharmaceuticals, Inc. |
Human Kallikrein
|
|
DE19632772A1
(de)
|
1996-08-14 |
1998-02-19 |
Basf Ag |
Neue Benzamidine
|
|
US6214966B1
(en)
|
1996-09-26 |
2001-04-10 |
Shearwater Corporation |
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
|
|
US6255455B1
(en)
|
1996-10-11 |
2001-07-03 |
The Trustees Of The University Of Pennsylvania |
Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
|
|
US6258351B1
(en)
|
1996-11-06 |
2001-07-10 |
Shearwater Corporation |
Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
|
|
CA2279345A1
(en)
|
1997-01-31 |
1998-08-06 |
Human Genome Sciences, Inc. |
Tissue factor pathway inhibitor-3
|
|
US5962300A
(en)
|
1997-03-26 |
1999-10-05 |
Incyte Pharmaceuticals, Inc. |
Human kallikrein
|
|
US5990237A
(en)
|
1997-05-21 |
1999-11-23 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
|
|
GB2339430A
(en)
|
1997-05-21 |
2000-01-26 |
Biovation Ltd |
Method for the production of non-immunogenic proteins
|
|
ES2211033T3
(es)
|
1998-01-07 |
2004-07-01 |
Debio Recherche Pharmaceutique S.A. |
Acrilatos de polietilenglicol heterobifuncionales degradables y geles y conjugados derivados de dichos acrilatos.
|
|
CA2323048C
(en)
|
1998-03-12 |
2006-10-10 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) derivatives with proximal reactive groups
|
|
KR100358276B1
(ko)
|
1998-03-24 |
2002-10-25 |
닛폰 유시 가부시키가이샤 |
옥시란 유도체 및 이의 제조방법
|
|
US6017723A
(en)
|
1998-03-27 |
2000-01-25 |
Long Island Jewish Medical Center |
Method for isolating inhibitors of protease activity
|
|
US6001596A
(en)
|
1998-05-07 |
1999-12-14 |
Incyte Pharmaceuticals, Inc. |
Growth-associated protease inhibitor heavy chain precursor
|
|
US6087473A
(en)
|
1999-05-26 |
2000-07-11 |
Zymogenetics, Inc. |
Kunitz domain polypeptide and materials and methods for making it
|
|
WO1999063090A2
(en)
|
1998-06-03 |
1999-12-09 |
Scios, Inc. |
Protease inhibitor peptides
|
|
US6783965B1
(en)
|
2000-02-10 |
2004-08-31 |
Mountain View Pharmaceuticals, Inc. |
Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
|
|
PT2316475T
(pt)
|
1998-08-06 |
2017-12-21 |
Univ Duke |
Uricase tetramérica isolada
|
|
AU5805499A
(en)
|
1998-09-03 |
2000-03-27 |
Zymogenetics Inc. |
Kunitz domain polypeptide zkun6
|
|
US7067144B2
(en)
|
1998-10-20 |
2006-06-27 |
Omeros Corporation |
Compositions and methods for systemic inhibition of cartilage degradation
|
|
JP2002531089A
(ja)
|
1998-11-30 |
2002-09-24 |
イーライ・リリー・アンド・カンパニー |
赤血球産生性化合物
|
|
DE69934967T2
(de)
|
1998-12-08 |
2007-12-06 |
Biovation Ltd. |
Verfahren zur verminderung der immunogenität von proteinen
|
|
US20030012969A1
(en)
|
1999-04-06 |
2003-01-16 |
Clark Bert Thomas |
Soluble membrane strengthened paper products
|
|
US6605316B1
(en)
|
1999-07-31 |
2003-08-12 |
The Regents Of The University Of California |
Structures and fabrication techniques for solid state electrochemical devices
|
|
US6180607B1
(en)
|
1999-08-05 |
2001-01-30 |
Christopher Davies |
Protein having proteinase inhibitor activity
|
|
EP1212422B1
(en)
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
|
KR20020065517A
(ko)
|
1999-11-12 |
2002-08-13 |
맥시겐 홀딩스 리미티드 |
인터페론 감마 접합체
|
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
|
US6544760B2
(en)
|
1999-12-22 |
2003-04-08 |
Zymogenetics, Inc. |
Kunitz domain polypeptide Zkun11
|
|
WO2001045796A2
(en)
|
1999-12-22 |
2001-06-28 |
Shearwater Corporation |
Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
|
|
US6413507B1
(en)
|
1999-12-23 |
2002-07-02 |
Shearwater Corporation |
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
|
|
US20020102703A1
(en)
|
1999-12-29 |
2002-08-01 |
Sheppard Paul O. |
Kunitz domain polypeptide zkun10
|
|
GB9930882D0
(en)
|
1999-12-30 |
2000-02-23 |
Nps Allelix Corp |
GLP-2 formulations
|
|
EP1274731A1
(en)
|
2000-03-13 |
2003-01-15 |
Eli Lilly And Company |
Human hepatocyte growth factor activator inhibitor homologue
|
|
AU2001261024A1
(en)
|
2000-04-12 |
2001-10-30 |
Delta Biotechnology Limited |
Albumin fusion proteins
|
|
CN1331213A
(zh)
|
2000-06-30 |
2002-01-16 |
上海博德基因开发有限公司 |
一种新的多肽——人大蛋白10.01和编码这种多肽的多核苷酸
|
|
DE10034357C1
(de)
|
2000-07-14 |
2001-12-13 |
Elotherm Gmbh |
Verfahren und Vorrichtung zum Härten von Flächen an Bauteilen
|
|
HK1048064B
(en)
|
2000-10-31 |
2004-02-13 |
Debiopharm S.A. |
A suspension of EPI-HNE protein and a preparation method thereof, a dry powder aerosol derived therefrom, a pharmaceutical composition containing the suspension or aerosol and application thereof
|
|
WO2002061131A2
(en)
|
2000-12-04 |
2002-08-08 |
Bristol-Myers Squibb Company |
Human single nucleotide polymorphisms
|
|
TW593427B
(en)
|
2000-12-18 |
2004-06-21 |
Nektar Therapeutics Al Corp |
Synthesis of high molecular weight non-peptidic polymer derivatives
|
|
US20020168323A1
(en)
|
2001-05-11 |
2002-11-14 |
Igor Gonda |
Optimization of the molecular properties and formulation of proteins delivered by inhalation
|
|
AR033903A1
(es)
|
2001-05-21 |
2004-01-07 |
Inhale Therapeutic Syst |
Una composicion de insulina modificada quimicamente para la administracion pulmonar
|
|
US20040152633A1
(en)
|
2001-05-31 |
2004-08-05 |
Jorgensen Marianne Ulrich |
Kunitz-type sequences and polypeptides
|
|
EP1406652A2
(en)
|
2001-07-10 |
2004-04-14 |
Omnio AB |
Novel drug targets for arthritis
|
|
US6913900B2
(en)
|
2001-08-29 |
2005-07-05 |
Nippon Zoki Pharmaceutical Co., Ltd. |
Plasma prekallikrein activation and kallikrein production assay
|
|
ATE556591T1
(de)
|
2001-11-08 |
2012-05-15 |
Abbott Biotherapeutics Corp |
Stabile pharmazeutische flüssigformulierung von igg-antikörpern
|
|
NZ534492A
(en)
|
2002-02-07 |
2009-10-30 |
Novozymes Delta Ltd |
Albumin-fused kunitz domain peptides
|
|
US7153829B2
(en)
|
2002-06-07 |
2006-12-26 |
Dyax Corp. |
Kallikrein-inhibitor therapies
|
|
ATE477020T1
(de)
|
2002-06-07 |
2010-08-15 |
Dyax Corp |
Prevention und verringerung von ischemia
|
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
|
KR100637981B1
(ko)
|
2002-07-24 |
2006-10-23 |
에프. 호프만-라 로슈 아게 |
페길화된 ｔ20 폴리펩타이드
|
|
JP4451308B2
(ja)
|
2002-07-24 |
2010-04-14 |
エフ．ホフマン−ラ ロシュ アーゲー |
ポリアルキレングリコール酸添加剤
|
|
ES2709103T3
(es)
|
2002-08-28 |
2019-04-15 |
Dyax Corp |
Métodos para conservar órganos y tejidos
|
|
US8129330B2
(en)
|
2002-09-30 |
2012-03-06 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
|
US20040062748A1
(en)
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
|
US7314613B2
(en)
|
2002-11-18 |
2008-01-01 |
Maxygen, Inc. |
Interferon-alpha polypeptides and conjugates
|
|
MXPA05006944A
(es)
|
2002-12-26 |
2005-12-14 |
Mountain View Pharmaceuticals |
Conjugados polimericos de interferon-beta cion potencia biologica aumentada.
|
|
JP2007524348A
(ja)
|
2003-01-07 |
2007-08-30 |
ダイアックス、コープ |
クニッツドメインライブラリー
|
|
ATE424215T1
(de)
|
2003-01-08 |
2009-03-15 |
Novartis Vaccines & Diagnostic |
Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante
|
|
DE602004015725D1
(de)
|
2003-01-08 |
2008-09-25 |
Novartis Vaccines & Diagnostic |
Stabilisierte lyophilisierte zubereitungen mit gewebefaktor-inhibitor (tfpi) oder varianten des gewebefaktor-inhibitors
|
|
US6989369B2
(en)
|
2003-02-07 |
2006-01-24 |
Dyax Corp. |
Kunitz domain peptides
|
|
AU2004266246A1
(en)
|
2003-08-14 |
2005-03-03 |
Dyax Corp. |
Endotheliase-2 ligands
|
|
CA2537113A1
(en)
|
2003-08-29 |
2005-03-10 |
Dyax Corp. |
Modified protease inhibitors
|
|
WO2005021557A2
(en)
|
2003-08-29 |
2005-03-10 |
Dyax Corp. |
Poly-pegylated protease inhibitors
|
|
EP1674480A4
(en)
|
2003-09-04 |
2007-06-20 |
Riken |
ANTIBODY RECOGNIZING THE REGIONAL SECTION CONTROLLING TGF-BETA ACTIVATION
|
|
WO2005027753A1
(en)
|
2003-09-19 |
2005-03-31 |
St. Jude Medical, Inc. |
Apparatus and methods for tissue gathering and securing
|
|
CA2930900C
(en)
|
2003-10-02 |
2018-10-16 |
Jazz Pharmaceuticals International Limited |
Combinations of ziconotide and opioids for reducing pain
|
|
US20060228331A1
(en)
|
2003-10-10 |
2006-10-12 |
Novo Nordisk A/S |
IL-21 Derivatives and variants
|
|
WO2005041631A2
(en)
|
2003-10-21 |
2005-05-12 |
Dyax Corp. |
Endotheliase-1 ligands
|
|
EP1713929A2
(en)
|
2004-02-03 |
2006-10-25 |
Bayer HealthCare AG |
Diagnostics and therapeutics for diseases associated with plasma kallikrein (klkb1)
|
|
JP2008515774A
(ja)
|
2004-08-03 |
2008-05-15 |
ダイアックス コーポレイション |
ｈＫ１結合タンパク質
|
|
US7235530B2
(en)
|
2004-09-27 |
2007-06-26 |
Dyax Corporation |
Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
|
|
EP1835926A4
(en)
|
2004-11-22 |
2009-04-01 |
Dyax Corp |
PLASMINE-INHIBITING THERAPIES
|
|
JP5118492B2
(ja)
|
2004-12-23 |
2013-01-16 |
ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー |
血栓の形成の防止および／または安定化の防止
|
|
US20060183771A1
(en)
|
2005-02-17 |
2006-08-17 |
Seiffert Dietmar A |
Novel combination of selective factor VIIa and/or factor XIa inhibitors and selective plasma kallikrein inhibitors
|
|
EP2295451A1
(en)
|
2005-05-04 |
2011-03-16 |
Zealand Pharma A/S |
Glucagon-like-peptide (GLP-2) analogues
|
|
US20070079096A1
(en)
|
2005-09-30 |
2007-04-05 |
Chih-Wei Chen |
Data storage unit access authorization table automatic rebuilding method and system
|
|
LT1981519T
(lt)
|
2005-12-29 |
2018-04-25 |
Dyax Corp. |
Proteazės slopinimas
|
|
US7276480B1
(en)
|
2005-12-30 |
2007-10-02 |
Dyax Corp. |
Prevention and reduction of blood loss
|
|
JP2009529542A
(ja)
|
2006-03-10 |
2009-08-20 |
ダイアックス コーポレーション |
エカランチドに関する配合物
|
|
LT1854477T
(lt)
|
2006-03-16 |
2016-12-12 |
Dyax Corp. |
Peptidai, slopinantys plazmos kalikreiną, skirti naudoti oftalmologinių sutrikimų gydymui
|
|
EP1873344A1
(de)
|
2006-06-30 |
2008-01-02 |
Sika Technology AG |
Mittels Silikon agedichtete Verklebung
|
|
WO2008016883A2
(en)
|
2006-07-31 |
2008-02-07 |
Activesite Pharmaceuticals, Inc. |
Inhibitors of plasma kallikrein
|
|
US20080299050A1
(en)
|
2006-10-05 |
2008-12-04 |
Drugtech Corporation |
Topical therapies for oral mucositis and other conditions
|
|
KR100846354B1
(ko)
|
2007-03-21 |
2008-07-15 |
(주) 프로탄바이오 |
혈청 당단백질부터 분리한 폐암 진단용 마커
|
|
US20090075887A1
(en)
|
2007-08-21 |
2009-03-19 |
Genzyme Corporation |
Treatment with Kallikrein Inhibitors
|
|
AU2008288772A1
(en)
|
2007-08-23 |
2009-02-26 |
Genzyme Corporation |
Treatment with kallikrein inhibitors
|
|
AU2009214590A1
(en)
|
2008-02-13 |
2009-08-20 |
Dyax Corp. |
Improved methods for producing specific binding pairs
|
|
DE102008027574A1
(de)
|
2008-06-10 |
2009-12-17 |
Merck Patent Gmbh |
Neue Pyrrolidinderivate als MetAP-2 Inhibitoren
|
|
DE102008033095A1
(de)
|
2008-07-15 |
2010-01-28 |
Uhde Gmbh |
Vorrichtung zur Schlackeabführung aus einem Kohlevergasungsreaktor
|
|
EP2385843A4
(en)
|
2009-01-06 |
2013-02-27 |
Dyax Corp |
TREATMENT OF MUZOSITIS WITH CALLICINE INHIBITORS
|
|
CN101928346B
(zh)
|
2009-07-31 |
2013-01-16 |
华中科技大学同济医学院附属同济医院 |
一种抗人组织激肽释放酶单克隆抗体及其制备
|
|
EP4011917A1
(en)
|
2010-01-06 |
2022-06-15 |
Takeda Pharmaceutical Company Limited |
Plasma kallikrein binding proteins
|
|
AU2012204202A1
(en)
|
2011-01-06 |
2013-07-11 |
Dyax Corp. |
Plasma kallikrein binding proteins
|
|
EP2697196A1
(en)
|
2011-04-13 |
2014-02-19 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
AU2012250872B2
(en)
|
2011-05-02 |
2017-07-13 |
Millennium Pharmaceuticals, Inc. |
Formulation for anti-alpha4beta7 antibody
|
|
WO2013123114A2
(en)
|
2012-02-16 |
2013-08-22 |
Santarus, Inc. |
Antibody formulations
|
|
US9216219B2
(en)
|
2012-06-12 |
2015-12-22 |
Novartis Ag |
Anti-BAFFR antibody formulation
|
|
AU2014207409B2
(en)
|
2013-01-20 |
2019-12-19 |
Takeda Pharmaceutical Company Limited |
Evaluation, assays and treatment of pKal-mediated disorders
|
|
IL273688B2
(en)
|
2013-01-20 |
2024-12-01 |
Dyax Corp |
Evaluation and treatment of bradykinin-mediated disorders
|
|
EP3594244A1
(en)
|
2013-03-15 |
2020-01-15 |
Dyax Corp. |
Anti-plasma kallikrein antibodies
|
|
KR20140119396A
(ko)
|
2013-03-29 |
2014-10-10 |
삼성전자주식회사 |
단백질 약물의 액상 제형
|
|
EA038532B1
(ru)
*
|
2014-01-21 |
2021-09-10 |
Такеда Фармасьютикал Компани Лимитед |
Способ лечения наследственного ангионевротического отека (hae)
|
|
KR20230109785A
(ko)
|
2014-03-27 |
2023-07-20 |
다케다 파머수티컬 컴패니 리미티드 |
당뇨병성 황반 부종의 치료를 위한 조성물 및 방법
|
|
BR112017020864A2
(en)
*
|
2015-03-30 |
2018-07-10 |
Dyax Corp. |
plasma kallikrein inhibitors and their uses for the prevention of hereditary angioedema attack
|
|
JP7585193B2
(ja)
|
2018-08-30 |
2024-11-18 |
武田薬品工業株式会社 |
血漿カリクレイン阻害剤及び遺伝性血管浮腫発作を処置するためのその使用
|
|
JP2022525164A
(ja)
|
2019-03-14 |
2022-05-11 |
武田薬品工業株式会社 |
遺伝性血管性浮腫の発作を処置するための血漿カリクレイン阻害剤およびその使用
|